Insulet (PODD) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Insulet (PODD) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | -429.00 |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 803.00 |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 260.00 |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 574.00 |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 764.00 |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 835.00 |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | -1,045.00 |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 598.00 |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 423.00 |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 762.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 762.00 |
| Mar 31, 2026 | 797.00 |
| Dec 31, 2025 | 1,186.00 |
| Sep 30, 2025 | 1,906.00 |
| Jun 30, 2025 | 1,643.00 |
| Mar 31, 2025 | -145.00 |
| Dec 31, 2024 | 779.00 |
| Sep 30, 2024 | 973.00 |
| Jun 30, 2024 | 2,125.00 |
| Mar 31, 2024 | 1,231.00 |
| Dec 31, 2023 | 2,868.00 |
| Sep 30, 2023 | 668.00 |
| Jun 30, 2023 | -50.00 |
| Mar 31, 2023 | 818.00 |
| Dec 31, 2022 | 278.00 |
| Sep 30, 2022 | -225.00 |
| Jun 30, 2022 | -1,313.00 |
| Mar 31, 2022 | 697.00 |
| Dec 31, 2021 | 427.00 |
| Sep 30, 2021 | 429.00 |